New Frontier Health Corporation Receives Notification from NYSE Regarding Delayed Filing of Semi-Annual Financial Information for the Half Year Ended June 30, 2021
January 11 2022 - 4:10PM
Business Wire
New Frontier Health Corporation (NYSE: NFH) (“NFH” or the
“Company”), the operator of the premium healthcare services
provider United Family Healthcare, today reported that, on January
4, 2022, the Company received a notice from the New York Stock
Exchange (the “NYSE”) Regulation stating that it is not in
compliance with the NYSE’s continued listing requirements under the
timely filing criteria pursuant to Section 802.01E of the NYSE
Listed Company Manual (the “Continued Listing Criteria”) as a
result of the Company’s failure to timely file its semi-annual
financial information for the half year ended June 30, 2021 on a
Current Report on Form 6-K (the “1H 2021 6-K”) with the SEC.
The NYSE informed the Company that, under the NYSE’s rules, the
Company has six months from December 31, 2021 to file the 1H 2021
6-K with the SEC (the “Automatic Cure Period”). If the Company
fails to file the 1H 2021 6-K within the Automatic Cure Period, the
NYSE may, in its sole discretion, allow the Company’s securities to
trade for up to an additional six months depending on specific
circumstances (the “Additional Cure Period”), as outlined in the
Continued Listing Criteria. If the NYSE determines that an
Additional Cure Period is not appropriate, suspension and delisting
procedures will commence pursuant to Section 804.00 of the NYSE
Listed Company Manual. If the NYSE determines that an Additional
Cure Period is appropriate and the Company fails to file the 1H
2021 6-K by the end of that period, suspension and delisting
procedures will generally commence. Regardless of the procedures
described above, the NYSE may commence delisting proceedings at any
time during the period that is available to the Company to complete
the filing of the 1H 2021 6-K, if circumstances warrant.
The Company has not yet filed the 1H 2021 6-K with the SEC
because it has focused its resources on its previously announced
going private transaction (the “Privatization”), which is expected
to close during the first quarter of 2022. If consummated, the
Privatization would result in the Company becoming a privately held
company and its ordinary shares and warrants would no longer be
listed on the NYSE. If the Company completes the Privatization
before the end of the Automatic Cure Period (or Additional Cure
Period, if applicable), the Company does not intend to file the 1H
2021 6-K since its securities will no longer be listed on the
NYSE.
About New Frontier Health Corporation
New Frontier Health Corporation is the operator of United Family
Healthcare (“UFH”), a leading private healthcare provider offering
comprehensive premium healthcare services in China through a
network of private hospitals and affiliated ambulatory clinics. UFH
currently has nine hospitals in operation or under construction in
all four tier 1 cities and selected tier 2 cities. Additional
information may be found at www.nfh.com.cn.
Forward-Looking Statements
Certain statements made in this release are “forward looking
statements” within the meaning of the “safe harbor” provisions of
the United States Private Securities Litigation Reform Act of 1995.
When used in this press release, the words “estimates,”
“projected,” “expects,” “anticipates,” “forecasts,” “plans,”
“intends,” “believes,” “seeks,” “may,” “will,” “should,” “future,”
“propose” and variations of these words or similar expressions (or
the negative versions of such words or expressions) are intended to
identify forward-looking statements. These forward-looking
statements include, without limitation, the ability of NFH to file
the 1H 2021 6-K, the possibility that the Privatization will not
occur as planned if events arise that result in the termination of
the merger agreement providing for the Privatization, if the
expected financing for the Privatization is not available for any
reason, or if one or more of the various closing conditions to the
Privatization are not satisfied or waived, and other risks and
uncertainties regarding the Privatization, as discussed in the
Schedule 13E-3 transaction statement, originally filed with the SEC
on October 5, 2021, as amended. These forward-looking statements
are not guarantees of future results and involve a number of known
and unknown risks, uncertainties, assumptions and other important
factors, many of which are outside NFH’s control, which could cause
actual results or outcomes to differ materially from those
discussed in the forward-looking statements. NFH undertakes no
obligation to update or revise any forward-looking statements,
whether as a result of new information, future events or otherwise,
except as required by law.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220111006082/en/
Investors Arthur, Yue Chen Tel: +86-150-0500-3258 Email:
arthur@new-frontier.com ICR, LLC William Zima Tel:
+1-203-682-8200 Email: bill.zima@icrinc.com Media Wenjing
Liu Tel: +86-10-5927-7342 Email: liu.wenjing@ufh.com.cn
New Frontier Health (NYSE:NFH)
Historical Stock Chart
From Oct 2024 to Nov 2024
New Frontier Health (NYSE:NFH)
Historical Stock Chart
From Nov 2023 to Nov 2024